Global Long-acting rhGH (LAGH) Market Growth 2026-2032
The global Long-acting rhGH (LAGH) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Recombinant human growth hormone is a protein that is manufactured to be nearly identical to the main form of the naturally occurring human growth hormone. This hormone can stimulate tissue growth, linear growth (height), and protein, carbohydrate, lipid, and mineral metabolism. It has approved indications in both the adult and pediatric populations.
Short-acting growth hormone requires daily injections, while long-acting recombinant human growth hormone only needs to be administered once a week.
United States market for Long-acting rhGH (LAGH) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-acting rhGH (LAGH) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-acting rhGH (LAGH) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-acting rhGH (LAGH) players cover Novo Nordisk, GeneScience Pharmaceutical, Pfizer, OPKO Health, Ascendis Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting rhGH (LAGH) Industry Forecast” looks at past sales and reviews total world Long-acting rhGH (LAGH) sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting rhGH (LAGH) sales for 2026 through 2032. With Long-acting rhGH (LAGH) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting rhGH (LAGH) industry.
This Insight Report provides a comprehensive analysis of the global Long-acting rhGH (LAGH) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting rhGH (LAGH) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting rhGH (LAGH) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting rhGH (LAGH) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting rhGH (LAGH).
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting rhGH (LAGH) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Recombinant human growth hormone is a protein that is manufactured to be nearly identical to the main form of the naturally occurring human growth hormone. This hormone can stimulate tissue growth, linear growth (height), and protein, carbohydrate, lipid, and mineral metabolism. It has approved indications in both the adult and pediatric populations.
Short-acting growth hormone requires daily injections, while long-acting recombinant human growth hormone only needs to be administered once a week.
United States market for Long-acting rhGH (LAGH) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-acting rhGH (LAGH) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-acting rhGH (LAGH) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-acting rhGH (LAGH) players cover Novo Nordisk, GeneScience Pharmaceutical, Pfizer, OPKO Health, Ascendis Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting rhGH (LAGH) Industry Forecast” looks at past sales and reviews total world Long-acting rhGH (LAGH) sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting rhGH (LAGH) sales for 2026 through 2032. With Long-acting rhGH (LAGH) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting rhGH (LAGH) industry.
This Insight Report provides a comprehensive analysis of the global Long-acting rhGH (LAGH) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting rhGH (LAGH) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting rhGH (LAGH) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting rhGH (LAGH) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting rhGH (LAGH).
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting rhGH (LAGH) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Powder
- Liquid
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Renal Insufficiency
- Prader Willi Syndrome
- Small for Gestational Age
- SHOX Deficiency
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- GeneScience Pharmaceutical
- Pfizer
- OPKO Health
- Ascendis Pharma
- Amunix Pharmaceuticals, Inc.
- I-MAB Biopharma
- What is the 10-year outlook for the global Long-acting rhGH (LAGH) market?
- What factors are driving Long-acting rhGH (LAGH) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Long-acting rhGH (LAGH) market opportunities vary by end market size?
- How does Long-acting rhGH (LAGH) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting rhGH (LAGH) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-acting rhGH (LAGH) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-acting rhGH (LAGH) by Country/Region, 2021, 2025 & 2032
2.2 Long-acting rhGH (LAGH) Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Long-acting rhGH (LAGH) Sales by Type
2.2.3.1 Global Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Long-acting rhGH (LAGH) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Long-acting rhGH (LAGH) Sale Price by Type (2021-2026)
2.3 Long-acting rhGH (LAGH) Segment by Application
2.3.1 Growth Hormone Deficiency (GHD)
2.3.2 Turner Syndrome
2.3.3 Chronic Renal Insufficiency
2.3.4 Prader Willi Syndrome
2.3.5 Small for Gestational Age
2.3.6 SHOX Deficiency
2.3.7 Others
2.3.8 Long-acting rhGH (LAGH) Sales by Application
2.3.8.1 Global Long-acting rhGH (LAGH) Sale Market Share by Application (2021-2026)
2.3.8.2 Global Long-acting rhGH (LAGH) Revenue and Market Share by Application (2021-2026)
2.3.8.3 Global Long-acting rhGH (LAGH) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-acting rhGH (LAGH) Breakdown Data by Company
3.1.1 Global Long-acting rhGH (LAGH) Annual Sales by Company (2021-2026)
3.1.2 Global Long-acting rhGH (LAGH) Sales Market Share by Company (2021-2026)
3.2 Global Long-acting rhGH (LAGH) Annual Revenue by Company (2021-2026)
3.2.1 Global Long-acting rhGH (LAGH) Revenue by Company (2021-2026)
3.2.2 Global Long-acting rhGH (LAGH) Revenue Market Share by Company (2021-2026)
3.3 Global Long-acting rhGH (LAGH) Sale Price by Company
3.4 Key Manufacturers Long-acting rhGH (LAGH) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting rhGH (LAGH) Product Location Distribution
3.4.2 Players Long-acting rhGH (LAGH) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING RHGH (LAGH) BY GEOGRAPHIC REGION
4.1 World Historic Long-acting rhGH (LAGH) Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-acting rhGH (LAGH) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-acting rhGH (LAGH) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-acting rhGH (LAGH) Market Size by Country/Region (2021-2026)
4.2.1 Global Long-acting rhGH (LAGH) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-acting rhGH (LAGH) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting rhGH (LAGH) Sales Growth
4.4 APAC Long-acting rhGH (LAGH) Sales Growth
4.5 Europe Long-acting rhGH (LAGH) Sales Growth
4.6 Middle East & Africa Long-acting rhGH (LAGH) Sales Growth
5 AMERICAS
5.1 Americas Long-acting rhGH (LAGH) Sales by Country
5.1.1 Americas Long-acting rhGH (LAGH) Sales by Country (2021-2026)
5.1.2 Americas Long-acting rhGH (LAGH) Revenue by Country (2021-2026)
5.2 Americas Long-acting rhGH (LAGH) Sales by Type (2021-2026)
5.3 Americas Long-acting rhGH (LAGH) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting rhGH (LAGH) Sales by Region
6.1.1 APAC Long-acting rhGH (LAGH) Sales by Region (2021-2026)
6.1.2 APAC Long-acting rhGH (LAGH) Revenue by Region (2021-2026)
6.2 APAC Long-acting rhGH (LAGH) Sales by Type (2021-2026)
6.3 APAC Long-acting rhGH (LAGH) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting rhGH (LAGH) by Country
7.1.1 Europe Long-acting rhGH (LAGH) Sales by Country (2021-2026)
7.1.2 Europe Long-acting rhGH (LAGH) Revenue by Country (2021-2026)
7.2 Europe Long-acting rhGH (LAGH) Sales by Type (2021-2026)
7.3 Europe Long-acting rhGH (LAGH) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting rhGH (LAGH) by Country
8.1.1 Middle East & Africa Long-acting rhGH (LAGH) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-acting rhGH (LAGH) Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-acting rhGH (LAGH) Sales by Type (2021-2026)
8.3 Middle East & Africa Long-acting rhGH (LAGH) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting rhGH (LAGH)
10.3 Manufacturing Process Analysis of Long-acting rhGH (LAGH)
10.4 Industry Chain Structure of Long-acting rhGH (LAGH)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting rhGH (LAGH) Distributors
11.3 Long-acting rhGH (LAGH) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING RHGH (LAGH) BY GEOGRAPHIC REGION
12.1 Global Long-acting rhGH (LAGH) Market Size Forecast by Region
12.1.1 Global Long-acting rhGH (LAGH) Forecast by Region (2027-2032)
12.1.2 Global Long-acting rhGH (LAGH) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-acting rhGH (LAGH) Forecast by Type (2027-2032)
12.7 Global Long-acting rhGH (LAGH) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 GeneScience Pharmaceutical
13.2.1 GeneScience Pharmaceutical Company Information
13.2.2 GeneScience Pharmaceutical Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.2.3 GeneScience Pharmaceutical Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GeneScience Pharmaceutical Main Business Overview
13.2.5 GeneScience Pharmaceutical Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.3.3 Pfizer Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 OPKO Health
13.4.1 OPKO Health Company Information
13.4.2 OPKO Health Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.4.3 OPKO Health Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 OPKO Health Main Business Overview
13.4.5 OPKO Health Latest Developments
13.5 Ascendis Pharma
13.5.1 Ascendis Pharma Company Information
13.5.2 Ascendis Pharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.5.3 Ascendis Pharma Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ascendis Pharma Main Business Overview
13.5.5 Ascendis Pharma Latest Developments
13.6 Amunix Pharmaceuticals, Inc.
13.6.1 Amunix Pharmaceuticals, Inc. Company Information
13.6.2 Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.6.3 Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Amunix Pharmaceuticals, Inc. Main Business Overview
13.6.5 Amunix Pharmaceuticals, Inc. Latest Developments
13.7 I-MAB Biopharma
13.7.1 I-MAB Biopharma Company Information
13.7.2 I-MAB Biopharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.7.3 I-MAB Biopharma Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 I-MAB Biopharma Main Business Overview
13.7.5 I-MAB Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting rhGH (LAGH) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-acting rhGH (LAGH) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-acting rhGH (LAGH) by Country/Region, 2021, 2025 & 2032
2.2 Long-acting rhGH (LAGH) Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.2.3 Long-acting rhGH (LAGH) Sales by Type
2.2.3.1 Global Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Long-acting rhGH (LAGH) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Long-acting rhGH (LAGH) Sale Price by Type (2021-2026)
2.3 Long-acting rhGH (LAGH) Segment by Application
2.3.1 Growth Hormone Deficiency (GHD)
2.3.2 Turner Syndrome
2.3.3 Chronic Renal Insufficiency
2.3.4 Prader Willi Syndrome
2.3.5 Small for Gestational Age
2.3.6 SHOX Deficiency
2.3.7 Others
2.3.8 Long-acting rhGH (LAGH) Sales by Application
2.3.8.1 Global Long-acting rhGH (LAGH) Sale Market Share by Application (2021-2026)
2.3.8.2 Global Long-acting rhGH (LAGH) Revenue and Market Share by Application (2021-2026)
2.3.8.3 Global Long-acting rhGH (LAGH) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-acting rhGH (LAGH) Breakdown Data by Company
3.1.1 Global Long-acting rhGH (LAGH) Annual Sales by Company (2021-2026)
3.1.2 Global Long-acting rhGH (LAGH) Sales Market Share by Company (2021-2026)
3.2 Global Long-acting rhGH (LAGH) Annual Revenue by Company (2021-2026)
3.2.1 Global Long-acting rhGH (LAGH) Revenue by Company (2021-2026)
3.2.2 Global Long-acting rhGH (LAGH) Revenue Market Share by Company (2021-2026)
3.3 Global Long-acting rhGH (LAGH) Sale Price by Company
3.4 Key Manufacturers Long-acting rhGH (LAGH) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting rhGH (LAGH) Product Location Distribution
3.4.2 Players Long-acting rhGH (LAGH) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING RHGH (LAGH) BY GEOGRAPHIC REGION
4.1 World Historic Long-acting rhGH (LAGH) Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-acting rhGH (LAGH) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-acting rhGH (LAGH) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-acting rhGH (LAGH) Market Size by Country/Region (2021-2026)
4.2.1 Global Long-acting rhGH (LAGH) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-acting rhGH (LAGH) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting rhGH (LAGH) Sales Growth
4.4 APAC Long-acting rhGH (LAGH) Sales Growth
4.5 Europe Long-acting rhGH (LAGH) Sales Growth
4.6 Middle East & Africa Long-acting rhGH (LAGH) Sales Growth
5 AMERICAS
5.1 Americas Long-acting rhGH (LAGH) Sales by Country
5.1.1 Americas Long-acting rhGH (LAGH) Sales by Country (2021-2026)
5.1.2 Americas Long-acting rhGH (LAGH) Revenue by Country (2021-2026)
5.2 Americas Long-acting rhGH (LAGH) Sales by Type (2021-2026)
5.3 Americas Long-acting rhGH (LAGH) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting rhGH (LAGH) Sales by Region
6.1.1 APAC Long-acting rhGH (LAGH) Sales by Region (2021-2026)
6.1.2 APAC Long-acting rhGH (LAGH) Revenue by Region (2021-2026)
6.2 APAC Long-acting rhGH (LAGH) Sales by Type (2021-2026)
6.3 APAC Long-acting rhGH (LAGH) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting rhGH (LAGH) by Country
7.1.1 Europe Long-acting rhGH (LAGH) Sales by Country (2021-2026)
7.1.2 Europe Long-acting rhGH (LAGH) Revenue by Country (2021-2026)
7.2 Europe Long-acting rhGH (LAGH) Sales by Type (2021-2026)
7.3 Europe Long-acting rhGH (LAGH) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting rhGH (LAGH) by Country
8.1.1 Middle East & Africa Long-acting rhGH (LAGH) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-acting rhGH (LAGH) Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-acting rhGH (LAGH) Sales by Type (2021-2026)
8.3 Middle East & Africa Long-acting rhGH (LAGH) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting rhGH (LAGH)
10.3 Manufacturing Process Analysis of Long-acting rhGH (LAGH)
10.4 Industry Chain Structure of Long-acting rhGH (LAGH)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting rhGH (LAGH) Distributors
11.3 Long-acting rhGH (LAGH) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING RHGH (LAGH) BY GEOGRAPHIC REGION
12.1 Global Long-acting rhGH (LAGH) Market Size Forecast by Region
12.1.1 Global Long-acting rhGH (LAGH) Forecast by Region (2027-2032)
12.1.2 Global Long-acting rhGH (LAGH) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-acting rhGH (LAGH) Forecast by Type (2027-2032)
12.7 Global Long-acting rhGH (LAGH) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 GeneScience Pharmaceutical
13.2.1 GeneScience Pharmaceutical Company Information
13.2.2 GeneScience Pharmaceutical Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.2.3 GeneScience Pharmaceutical Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GeneScience Pharmaceutical Main Business Overview
13.2.5 GeneScience Pharmaceutical Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.3.3 Pfizer Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 OPKO Health
13.4.1 OPKO Health Company Information
13.4.2 OPKO Health Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.4.3 OPKO Health Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 OPKO Health Main Business Overview
13.4.5 OPKO Health Latest Developments
13.5 Ascendis Pharma
13.5.1 Ascendis Pharma Company Information
13.5.2 Ascendis Pharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.5.3 Ascendis Pharma Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Ascendis Pharma Main Business Overview
13.5.5 Ascendis Pharma Latest Developments
13.6 Amunix Pharmaceuticals, Inc.
13.6.1 Amunix Pharmaceuticals, Inc. Company Information
13.6.2 Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.6.3 Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Amunix Pharmaceuticals, Inc. Main Business Overview
13.6.5 Amunix Pharmaceuticals, Inc. Latest Developments
13.7 I-MAB Biopharma
13.7.1 I-MAB Biopharma Company Information
13.7.2 I-MAB Biopharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
13.7.3 I-MAB Biopharma Long-acting rhGH (LAGH) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 I-MAB Biopharma Main Business Overview
13.7.5 I-MAB Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting rhGH (LAGH) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-acting rhGH (LAGH) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 6. Global Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Table 7. Global Long-acting rhGH (LAGH) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2021-2026)
Table 9. Global Long-acting rhGH (LAGH) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Long-acting rhGH (LAGH) Sale by Application (2021-2026) & (K Units)
Table 11. Global Long-acting rhGH (LAGH) Sale Market Share by Application (2021-2026)
Table 12. Global Long-acting rhGH (LAGH) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Long-acting rhGH (LAGH) Revenue Market Share by Application (2021-2026)
Table 14. Global Long-acting rhGH (LAGH) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Long-acting rhGH (LAGH) Sales by Company (2021-2026) & (K Units)
Table 16. Global Long-acting rhGH (LAGH) Sales Market Share by Company (2021-2026)
Table 17. Global Long-acting rhGH (LAGH) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Long-acting rhGH (LAGH) Revenue Market Share by Company (2021-2026)
Table 19. Global Long-acting rhGH (LAGH) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Long-acting rhGH (LAGH) Producing Area Distribution and Sales Area
Table 21. Players Long-acting rhGH (LAGH) Products Offered
Table 22. Long-acting rhGH (LAGH) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Long-acting rhGH (LAGH) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Long-acting rhGH (LAGH) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Long-acting rhGH (LAGH) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Long-acting rhGH (LAGH) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Long-acting rhGH (LAGH) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Long-acting rhGH (LAGH) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Long-acting rhGH (LAGH) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Long-acting rhGH (LAGH) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Long-acting rhGH (LAGH) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Long-acting rhGH (LAGH) Sales Market Share by Country (2021-2026)
Table 35. Americas Long-acting rhGH (LAGH) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Long-acting rhGH (LAGH) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Long-acting rhGH (LAGH) Sales Market Share by Region (2021-2026)
Table 40. APAC Long-acting rhGH (LAGH) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Long-acting rhGH (LAGH) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Long-acting rhGH (LAGH) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Long-acting rhGH (LAGH) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Long-acting rhGH (LAGH) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Long-acting rhGH (LAGH)
Table 52. Key Market Challenges & Risks of Long-acting rhGH (LAGH)
Table 53. Key Industry Trends of Long-acting rhGH (LAGH)
Table 54. Long-acting rhGH (LAGH) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Long-acting rhGH (LAGH) Distributors List
Table 57. Long-acting rhGH (LAGH) Customer List
Table 58. Global Long-acting rhGH (LAGH) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Long-acting rhGH (LAGH) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Long-acting rhGH (LAGH) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Long-acting rhGH (LAGH) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Long-acting rhGH (LAGH) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Long-acting rhGH (LAGH) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Long-acting rhGH (LAGH) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Long-acting rhGH (LAGH) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Long-acting rhGH (LAGH) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Long-acting rhGH (LAGH) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Long-acting rhGH (LAGH) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Long-acting rhGH (LAGH) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Long-acting rhGH (LAGH) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Long-acting rhGH (LAGH) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 74. Novo Nordisk Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. GeneScience Pharmaceutical Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 78. GeneScience Pharmaceutical Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 79. GeneScience Pharmaceutical Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. GeneScience Pharmaceutical Main Business
Table 81. GeneScience Pharmaceutical Latest Developments
Table 82. Pfizer Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 84. Pfizer Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. OPKO Health Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 88. OPKO Health Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 89. OPKO Health Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. OPKO Health Main Business
Table 91. OPKO Health Latest Developments
Table 92. Ascendis Pharma Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 93. Ascendis Pharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 94. Ascendis Pharma Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Ascendis Pharma Main Business
Table 96. Ascendis Pharma Latest Developments
Table 97. Amunix Pharmaceuticals, Inc. Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 98. Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 99. Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Amunix Pharmaceuticals, Inc. Main Business
Table 101. Amunix Pharmaceuticals, Inc. Latest Developments
Table 102. I-MAB Biopharma Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 103. I-MAB Biopharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 104. I-MAB Biopharma Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. I-MAB Biopharma Main Business
Table 106. I-MAB Biopharma Latest Developments
Table 1. Long-acting rhGH (LAGH) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-acting rhGH (LAGH) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 6. Global Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Table 7. Global Long-acting rhGH (LAGH) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2021-2026)
Table 9. Global Long-acting rhGH (LAGH) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Long-acting rhGH (LAGH) Sale by Application (2021-2026) & (K Units)
Table 11. Global Long-acting rhGH (LAGH) Sale Market Share by Application (2021-2026)
Table 12. Global Long-acting rhGH (LAGH) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Long-acting rhGH (LAGH) Revenue Market Share by Application (2021-2026)
Table 14. Global Long-acting rhGH (LAGH) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Long-acting rhGH (LAGH) Sales by Company (2021-2026) & (K Units)
Table 16. Global Long-acting rhGH (LAGH) Sales Market Share by Company (2021-2026)
Table 17. Global Long-acting rhGH (LAGH) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Long-acting rhGH (LAGH) Revenue Market Share by Company (2021-2026)
Table 19. Global Long-acting rhGH (LAGH) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Long-acting rhGH (LAGH) Producing Area Distribution and Sales Area
Table 21. Players Long-acting rhGH (LAGH) Products Offered
Table 22. Long-acting rhGH (LAGH) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Long-acting rhGH (LAGH) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Long-acting rhGH (LAGH) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Long-acting rhGH (LAGH) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Long-acting rhGH (LAGH) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Long-acting rhGH (LAGH) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Long-acting rhGH (LAGH) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Long-acting rhGH (LAGH) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Long-acting rhGH (LAGH) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Long-acting rhGH (LAGH) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Long-acting rhGH (LAGH) Sales Market Share by Country (2021-2026)
Table 35. Americas Long-acting rhGH (LAGH) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Long-acting rhGH (LAGH) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Long-acting rhGH (LAGH) Sales Market Share by Region (2021-2026)
Table 40. APAC Long-acting rhGH (LAGH) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Long-acting rhGH (LAGH) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Long-acting rhGH (LAGH) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Long-acting rhGH (LAGH) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Long-acting rhGH (LAGH) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Long-acting rhGH (LAGH) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-acting rhGH (LAGH) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Long-acting rhGH (LAGH)
Table 52. Key Market Challenges & Risks of Long-acting rhGH (LAGH)
Table 53. Key Industry Trends of Long-acting rhGH (LAGH)
Table 54. Long-acting rhGH (LAGH) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Long-acting rhGH (LAGH) Distributors List
Table 57. Long-acting rhGH (LAGH) Customer List
Table 58. Global Long-acting rhGH (LAGH) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Long-acting rhGH (LAGH) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Long-acting rhGH (LAGH) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Long-acting rhGH (LAGH) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Long-acting rhGH (LAGH) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Long-acting rhGH (LAGH) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Long-acting rhGH (LAGH) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Long-acting rhGH (LAGH) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Long-acting rhGH (LAGH) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Long-acting rhGH (LAGH) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Long-acting rhGH (LAGH) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Long-acting rhGH (LAGH) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Long-acting rhGH (LAGH) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Long-acting rhGH (LAGH) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 74. Novo Nordisk Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. GeneScience Pharmaceutical Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 78. GeneScience Pharmaceutical Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 79. GeneScience Pharmaceutical Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. GeneScience Pharmaceutical Main Business
Table 81. GeneScience Pharmaceutical Latest Developments
Table 82. Pfizer Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 84. Pfizer Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. OPKO Health Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 88. OPKO Health Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 89. OPKO Health Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. OPKO Health Main Business
Table 91. OPKO Health Latest Developments
Table 92. Ascendis Pharma Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 93. Ascendis Pharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 94. Ascendis Pharma Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Ascendis Pharma Main Business
Table 96. Ascendis Pharma Latest Developments
Table 97. Amunix Pharmaceuticals, Inc. Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 98. Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 99. Amunix Pharmaceuticals, Inc. Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Amunix Pharmaceuticals, Inc. Main Business
Table 101. Amunix Pharmaceuticals, Inc. Latest Developments
Table 102. I-MAB Biopharma Basic Information, Long-acting rhGH (LAGH) Manufacturing Base, Sales Area and Its Competitors
Table 103. I-MAB Biopharma Long-acting rhGH (LAGH) Product Portfolios and Specifications
Table 104. I-MAB Biopharma Long-acting rhGH (LAGH) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. I-MAB Biopharma Main Business
Table 106. I-MAB Biopharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting rhGH (LAGH)
Figure 2. Long-acting rhGH (LAGH) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting rhGH (LAGH) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-acting rhGH (LAGH) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-acting rhGH (LAGH) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-acting rhGH (LAGH) Sales Market Share by Country/Region (2025)
Figure 10. Long-acting rhGH (LAGH) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Long-acting rhGH (LAGH) Sales Market Share by Type in 2026
Figure 14. Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2021-2026)
Figure 15. Long-acting rhGH (LAGH) Consumed in Growth Hormone Deficiency (GHD)
Figure 16. Global Long-acting rhGH (LAGH) Market: Growth Hormone Deficiency (GHD) (2021-2026) & (K Units)
Figure 17. Long-acting rhGH (LAGH) Consumed in Turner Syndrome
Figure 18. Global Long-acting rhGH (LAGH) Market: Turner Syndrome (2021-2026) & (K Units)
Figure 19. Long-acting rhGH (LAGH) Consumed in Chronic Renal Insufficiency
Figure 20. Global Long-acting rhGH (LAGH) Market: Chronic Renal Insufficiency (2021-2026) & (K Units)
Figure 21. Long-acting rhGH (LAGH) Consumed in Prader Willi Syndrome
Figure 22. Global Long-acting rhGH (LAGH) Market: Prader Willi Syndrome (2021-2026) & (K Units)
Figure 23. Long-acting rhGH (LAGH) Consumed in Small for Gestational Age
Figure 24. Global Long-acting rhGH (LAGH) Market: Small for Gestational Age (2021-2026) & (K Units)
Figure 25. Long-acting rhGH (LAGH) Consumed in SHOX Deficiency
Figure 26. Global Long-acting rhGH (LAGH) Market: SHOX Deficiency (2021-2026) & (K Units)
Figure 27. Long-acting rhGH (LAGH) Consumed in Others
Figure 28. Global Long-acting rhGH (LAGH) Market: Others (2021-2026) & (K Units)
Figure 29. Global Long-acting rhGH (LAGH) Sale Market Share by Application (2025)
Figure 30. Global Long-acting rhGH (LAGH) Revenue Market Share by Application in 2026
Figure 31. Long-acting rhGH (LAGH) Sales by Company in 2026 (K Units)
Figure 32. Global Long-acting rhGH (LAGH) Sales Market Share by Company in 2026
Figure 33. Long-acting rhGH (LAGH) Revenue by Company in 2026 ($ millions)
Figure 34. Global Long-acting rhGH (LAGH) Revenue Market Share by Company in 2026
Figure 35. Global Long-acting rhGH (LAGH) Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Long-acting rhGH (LAGH) Revenue Market Share by Geographic Region in 2026
Figure 37. Americas Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 38. Americas Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 39. APAC Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 40. APAC Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 41. Europe Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 42. Europe Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 45. Americas Long-acting rhGH (LAGH) Sales Market Share by Country in 2026
Figure 46. Americas Long-acting rhGH (LAGH) Revenue Market Share by Country (2021-2026)
Figure 47. Americas Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 48. Americas Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 49. United States Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Long-acting rhGH (LAGH) Sales Market Share by Region in 2026
Figure 54. APAC Long-acting rhGH (LAGH) Revenue Market Share by Region (2021-2026)
Figure 55. APAC Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 56. APAC Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 57. China Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 61. India Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Long-acting rhGH (LAGH) Sales Market Share by Country in 2026
Figure 65. Europe Long-acting rhGH (LAGH) Revenue Market Share by Country (2021-2026)
Figure 66. Europe Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 67. Europe Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 68. Germany Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 69. France Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Long-acting rhGH (LAGH) Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 76. Egypt Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Long-acting rhGH (LAGH) in 2026
Figure 82. Manufacturing Process Analysis of Long-acting rhGH (LAGH)
Figure 83. Industry Chain Structure of Long-acting rhGH (LAGH)
Figure 84. Channels of Distribution
Figure 85. Global Long-acting rhGH (LAGH) Sales Market Forecast by Region (2027-2032)
Figure 86. Global Long-acting rhGH (LAGH) Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Long-acting rhGH (LAGH) Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Long-acting rhGH (LAGH) Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Long-acting rhGH (LAGH) Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Long-acting rhGH (LAGH) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Long-acting rhGH (LAGH)
Figure 2. Long-acting rhGH (LAGH) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting rhGH (LAGH) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-acting rhGH (LAGH) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-acting rhGH (LAGH) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-acting rhGH (LAGH) Sales Market Share by Country/Region (2025)
Figure 10. Long-acting rhGH (LAGH) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Powder
Figure 12. Product Picture of Liquid
Figure 13. Global Long-acting rhGH (LAGH) Sales Market Share by Type in 2026
Figure 14. Global Long-acting rhGH (LAGH) Revenue Market Share by Type (2021-2026)
Figure 15. Long-acting rhGH (LAGH) Consumed in Growth Hormone Deficiency (GHD)
Figure 16. Global Long-acting rhGH (LAGH) Market: Growth Hormone Deficiency (GHD) (2021-2026) & (K Units)
Figure 17. Long-acting rhGH (LAGH) Consumed in Turner Syndrome
Figure 18. Global Long-acting rhGH (LAGH) Market: Turner Syndrome (2021-2026) & (K Units)
Figure 19. Long-acting rhGH (LAGH) Consumed in Chronic Renal Insufficiency
Figure 20. Global Long-acting rhGH (LAGH) Market: Chronic Renal Insufficiency (2021-2026) & (K Units)
Figure 21. Long-acting rhGH (LAGH) Consumed in Prader Willi Syndrome
Figure 22. Global Long-acting rhGH (LAGH) Market: Prader Willi Syndrome (2021-2026) & (K Units)
Figure 23. Long-acting rhGH (LAGH) Consumed in Small for Gestational Age
Figure 24. Global Long-acting rhGH (LAGH) Market: Small for Gestational Age (2021-2026) & (K Units)
Figure 25. Long-acting rhGH (LAGH) Consumed in SHOX Deficiency
Figure 26. Global Long-acting rhGH (LAGH) Market: SHOX Deficiency (2021-2026) & (K Units)
Figure 27. Long-acting rhGH (LAGH) Consumed in Others
Figure 28. Global Long-acting rhGH (LAGH) Market: Others (2021-2026) & (K Units)
Figure 29. Global Long-acting rhGH (LAGH) Sale Market Share by Application (2025)
Figure 30. Global Long-acting rhGH (LAGH) Revenue Market Share by Application in 2026
Figure 31. Long-acting rhGH (LAGH) Sales by Company in 2026 (K Units)
Figure 32. Global Long-acting rhGH (LAGH) Sales Market Share by Company in 2026
Figure 33. Long-acting rhGH (LAGH) Revenue by Company in 2026 ($ millions)
Figure 34. Global Long-acting rhGH (LAGH) Revenue Market Share by Company in 2026
Figure 35. Global Long-acting rhGH (LAGH) Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Long-acting rhGH (LAGH) Revenue Market Share by Geographic Region in 2026
Figure 37. Americas Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 38. Americas Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 39. APAC Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 40. APAC Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 41. Europe Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 42. Europe Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Long-acting rhGH (LAGH) Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Long-acting rhGH (LAGH) Revenue 2021-2026 ($ millions)
Figure 45. Americas Long-acting rhGH (LAGH) Sales Market Share by Country in 2026
Figure 46. Americas Long-acting rhGH (LAGH) Revenue Market Share by Country (2021-2026)
Figure 47. Americas Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 48. Americas Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 49. United States Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Long-acting rhGH (LAGH) Sales Market Share by Region in 2026
Figure 54. APAC Long-acting rhGH (LAGH) Revenue Market Share by Region (2021-2026)
Figure 55. APAC Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 56. APAC Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 57. China Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 61. India Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Long-acting rhGH (LAGH) Sales Market Share by Country in 2026
Figure 65. Europe Long-acting rhGH (LAGH) Revenue Market Share by Country (2021-2026)
Figure 66. Europe Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 67. Europe Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 68. Germany Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 69. France Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Long-acting rhGH (LAGH) Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Long-acting rhGH (LAGH) Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Long-acting rhGH (LAGH) Sales Market Share by Application (2021-2026)
Figure 76. Egypt Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Long-acting rhGH (LAGH) Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Long-acting rhGH (LAGH) in 2026
Figure 82. Manufacturing Process Analysis of Long-acting rhGH (LAGH)
Figure 83. Industry Chain Structure of Long-acting rhGH (LAGH)
Figure 84. Channels of Distribution
Figure 85. Global Long-acting rhGH (LAGH) Sales Market Forecast by Region (2027-2032)
Figure 86. Global Long-acting rhGH (LAGH) Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Long-acting rhGH (LAGH) Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Long-acting rhGH (LAGH) Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Long-acting rhGH (LAGH) Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Long-acting rhGH (LAGH) Revenue Market Share Forecast by Application (2027-2032)
